{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:07:14Z","timestamp":1778641634286,"version":"3.51.4"},"reference-count":16,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,12]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Practice variation exists in the management of newly diagnosed pediatric immune thrombocytopenia (ITP) despite the availability of evidence-based treatment guidelines. The American Society of Hematology (ASH) ITP guidelines recommend that the initial treatment of children should be based on an assessment of clinical symptoms rather than the degree of thrombocytopenia and that short courses of corticosteroids should be prescribed to children requiring initial medication treatment. Retrospective review evaluating the treatment of newly diagnosed children with ITP has demonstrated that management continues to be based on the platelet count, with high use of IV immunoglobulin, which results in overuse of medications and high rates of inpatient hospitalizations and medical visits for the administration and management of side effects. To improve adherence to ASH guidelines, the ITP Consortium of North America implemented a clinical care pathway as a multicenter quality improvement initiative. Retrospective data (11 centers; n = 284) were collected before implementation and compared to postimplementation data (12 centers; n = 266). With implementation of the clinical pathway, documentation of a bleeding score for children at diagnosis increased from 1% (3\/284) to 95% (253\/266). At diagnosis, initial treatment with ITP-directed medications decreased in children with no or mild bleeding symptoms (62% [177\/284] vs 31% [83\/266]; P&amp;lt; .0001). IV immunoglobulin use reduced from 51% (145\/284) to 15% (41\/266; P&amp;lt; .0001). With implementation of the pathway, clinical outcomes were comparable with no increase in inpatient hospitalizations or bleeding events. Implementation of a clinical care pathway for a rare condition increases adherence to evidence-based guidelines and is feasible to implement across multiple centers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025018690","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T21:40:43Z","timestamp":1770327643000},"page":"3304-3312","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Multicenter initiative to standardize management of pediatric immune thrombocytopenia improves adherence to guidelines"],"prefix":"10.1182","volume":"10","author":[{"given":"Elizabeth","family":"Gunn","sequence":"first","affiliation":[{"name":"1Department of Pediatrics, Children\u2019s Healthcare of Atlanta, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo A.","family":"Angulo","sequence":"additional","affiliation":[{"name":"2Division of Pediatric Medical Oncology, Banner Health, Meza, AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4739-265X","authenticated-orcid":false,"given":"Sherif M.","family":"Badawy","sequence":"additional","affiliation":[{"name":"3Ann & Robert H. Lurie Children\u2019s Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Davini","sequence":"additional","affiliation":[{"name":"4Division of Pediatric Hematology\/Oncology, Banner Health, Tuscan, AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Elkus","sequence":"additional","affiliation":[{"name":"5Department of Pediatrics, Akron Children\u2019s Cancer and Blood Disorders Center, Akron, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7080-2293","authenticated-orcid":false,"given":"Kirsty","family":"Hillier","sequence":"additional","affiliation":[{"name":"6Hassenfeld Children\u2019s Hospital at NYU Langone Health, NYU Grossman School of Medicine, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shipra","family":"Kaicker","sequence":"additional","affiliation":[{"name":"7Division of Pediatric Hematology and Oncology, Weill Cornell Medicine, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5011-1022","authenticated-orcid":false,"given":"Jeffrey","family":"Lebensburger","sequence":"additional","affiliation":[{"name":"8Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeti","family":"Luke","sequence":"additional","affiliation":[{"name":"9Hematology OncologyPediatric Hematology Oncology, Children\u2019s Minnesota Hospital, Minneapolis, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn E.","family":"Scott","sequence":"additional","affiliation":[{"name":"10Department of Pediatrics, Upstate Medical University, Syracuse, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taizo A.","family":"Nakano","sequence":"additional","affiliation":[{"name":"11Center for Cancer and Blood Disorders, Children\u2019s Hospital Colorado, University of Colorado School of Medicine, Aurora, CO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Remiker","sequence":"additional","affiliation":[{"name":"12Department of Pediatrics, Children\u2019s Wisconsin, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey","family":"Rifkin-Zenenberg","sequence":"additional","affiliation":[{"name":"13Division of Pediatric Hematology and Oncology, Joseph M. Sanzari Children\u2019s Hospital at Hackensack University Medical Center, Hackensack, NJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7620-1819","authenticated-orcid":false,"given":"Corinna L.","family":"Schultz","sequence":"additional","affiliation":[{"name":"14Lisa Dean Moseley Foundation Institute for Cancer and Blood Disorders, Nemours Children\u2019s Health, Wilmington, DE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylah","family":"Buissereth","sequence":"additional","affiliation":[{"name":"15Dana-Farber\/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Carrier","sequence":"additional","affiliation":[{"name":"15Dana-Farber\/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Durney","sequence":"additional","affiliation":[{"name":"16Department of Pediatrics, Boston Children\u2019s Hospital, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Dekermanji","sequence":"additional","affiliation":[{"name":"16Department of Pediatrics, Boston Children\u2019s Hospital, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7302-0449","authenticated-orcid":false,"given":"Rachael F.","family":"Grace","sequence":"additional","affiliation":[{"name":"15Dana-Farber\/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"issue":"15","key":"2026051211212444900_bib1","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","article-title":"Why don't physicians follow clinical practice guidelines? A framework for improvement","volume":"282","author":"Cabana","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"2026051211212444900_bib2","doi-asserted-by":"crossref","first-page":"e29471","DOI":"10.1002\/pbc.29471","article-title":"System's failure: poor adherence to guidelines for children with sickle cell disease","volume":"69","author":"Vistica Sampino","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"2026051211212444900_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.thromres.2022.12.001","article-title":"Adherence to thrombophilia testing guidelines and its influence on anticoagulation therapy: a single-center cross-sectional study","volume":"223","author":"Vrotniakaite-Bajerciene","year":"2023","journal-title":"Thromb Res"},{"issue":"26","key":"2026051211212444900_bib4","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1056\/NEJMsa022615","article-title":"The quality of health care delivered to adults in the United States","volume":"348","author":"McGlynn","year":"2003","journal-title":"N Engl J Med"},{"issue":"3","key":"2026051211212444900_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/09537104.2019.1635687","article-title":"The incidence and clinical burden of immune thrombocytopenia in pediatric patients in the United States","volume":"31","author":"Shaw","year":"2020","journal-title":"Platelets"},{"issue":"5","key":"2026051211212444900_bib6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1067\/S0022-3476(03)00535-3","article-title":"A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group","volume":"143","author":"Kuhne","year":"2003","journal-title":"J Pediatr"},{"issue":"22","key":"2026051211212444900_bib7","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1182\/blood-2012-12-466375","article-title":"Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS)","volume":"121","author":"Neunert","year":"2013","journal-title":"Blood"},{"issue":"9","key":"2026051211212444900_bib8","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1182\/blood-2018-02-830844","article-title":"Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial","volume":"132","author":"Heitink-Polle","year":"2018","journal-title":"Blood"},{"issue":"23","key":"2026051211212444900_bib9","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv"},{"issue":"5","key":"2026051211212444900_bib10","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1542\/peds.2012-2021","article-title":"Patterns of inpatient care for newly diagnosed immune thrombocytopenia in US children's hospitals","volume":"131","author":"Kime","year":"2013","journal-title":"Pediatrics"},{"issue":"12","key":"2026051211212444900_bib11","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.3324\/haematol.2011.050799","article-title":"Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group","volume":"96","author":"Kuhne","year":"2011","journal-title":"Haematologica"},{"issue":"5","key":"2026051211212444900_bib12","doi-asserted-by":"crossref","first-page":"10.1002\/pbc.26303","DOI":"10.1002\/pbc.26303","article-title":"Increasing observation rates in low-risk pediatric immune thrombocytopenia using a standardized clinical assessment and management plan (SCAMPR)","volume":"64","author":"Schoettler","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2026051211212444900_bib13","doi-asserted-by":"crossref","first-page":"e30074","DOI":"10.1002\/pbc.30074","article-title":"Utilization of an ITP quality improvement pathway improves adherence to management guidelines","volume":"70","author":"Harris","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"2026051211212444900_bib14","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/bmjqs-2015-004411","article-title":"SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process","volume":"25","author":"Ogrinc","year":"2016","journal-title":"BMJ Qual Saf"},{"issue":"16","key":"2026051211212444900_bib15","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2026051211212444900_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/9\/3304\/2518976\/blooda_adv-2025-018690-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/9\/3304\/2518976\/blooda_adv-2025-018690-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:21:28Z","timestamp":1778599288000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/9\/3304\/566438\/Multicenter-initiative-to-standardize-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,5,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018690","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,12]]},"published":{"date-parts":[[2026,5,12]]}}}